Pandion Therapeutics Inc (PAND) Stock News

Ex-FBI Trainee Gets 15 Months for Trading on Girlfriend’s Info

The pandemic forced millions of people to share working spaces with their partners or spouses while shut in their homes. For some, such as former FBI trainee Seth Markin, the close proximity led to temptation.

Mentions: MRK

BREAKING NEWS ALERT: Halper Sadeh LLP Investigates CTB, FFG, PAND, SVBI, FPRX; Shareholders are Encouraged to Contact the Firm

Mentions: FPRX SVBI CTB FFG

SHAREHOLDER ALERT: WeissLaw LLP Reminds FI, SVBI, FRPX, and PAND Shareholders About Its Ongoing Investigations

Mentions: FPRX SVBI FI

Analyzing The Price Action In Pandion Therapeutics Stock Today

The Price And Volume Action In Pandion Therapeutics's Stock Today Pandion Therapeutics's (NASDAQ:

SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

Mentions: AEGN CHNG FLIR LACQ

INVESTIGATION ALERT: Halper Sadeh LLP Investigates CMD, COHR, PRSP, CUB, PAND; Shareholders are Encouraged to Contact the Firm

Mentions: COHR CMD CUB PRSP

SHAREHOLDER ALERT: WeissLaw LLP Reminds SVBI, FRPX, PAND and VKIN Shareholders About Its Ongoing Investigations

Mentions: SVBI VKIN

SHAREHOLDER ALERT: WeissLaw LLP Reminds PAND, VKIN, CLGX, and VGAC Shareholders About Its Ongoing Investigations

Mentions: CEI CLGX VGAC VKIN

ALERT: Halper Sadeh LLP Investigates WIFI, PRAH, PAND, CTB; Shareholders are Encouraged to Contact the Firm

Mentions: PRAH WIFI CTB

The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 2) Bioanalytical Systems, Inc...

Mentions: ITOS MOR KMPH NRIX ...

Lifshitz Law Firm, P.C. Announces Investigation of APEX, CTB, GT, FRTA, PAND, PRAH, ICLR, PBCT and MBT

Mentions: FRTA GT ICLR PBCT ...

PANDION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pandion Therapeutics, Inc. - PAND

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Pandion Therapeutics, Inc. - PAND

Are These The Top Biotech Stocks To Buy In March? 4 Names To Consider

Will biotech stocks show momentum like how they did last year? Let’s find out.

Mentions: VRTX MRNA PFE MRK ...

INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER

Mentions: CRHM AEGN PRAH AKER ...

Why Pandion Therapeutics Stock Blasted Sky-High on Thursday

You'd vault into the air too if a big-name pharmaceutical paid a high premium for your stock.

Mentions: MRK

SHAREHOLDER ALERT: WeissLaw LLP Investigates Pandion Therapeutics, Inc.

Mentions: MRK

Pandion Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Pandion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PAND

PAND Stock: Why Pandion Therapeutics Shares Have Skyrocketed Today

Pandion Therapeutics (PAND) stock is soaring higher on Thursday after announcing that Merck (MRK) plans to acquire the biotechnology company.

Mentions: MRK

Pandion Therapeutics Surges To Record High On Merck's $1.85 Billion Buyout

Pandion Therapeutics stock blasted to a record high Thursday on Merck's plan to buy the IPO stock for $1.85 billion. Pandion completed its IPO in July.

Mentions: MRK SNY